Prescribe FIT, a trailblazer in remote patient monitoring (RPM) technology and lifestyle health coaching, has successfully secured $4.8 million in Series A funding. The company, which has grown threefold in the past year, is dedicated to addressing the root causes of orthopedic patients' musculoskeletal conditions. By focusing on both surgical and non-surgical outcomes, Prescribe FIT's virtual program aims to prevent future injuries and enhance the overall well-being of patients.
Mike Kaufmann, a board member and former CEO of Cardinal Health, praised the company's impact on local communities. He noted that Prescribe FIT helps orthopedic surgeons significantly improve their patients' health and well-being, with patients often sharing life-changing testimonials. One patient, Shawna Ott, experienced remarkable improvements after participating in the program. Ott, who struggled with obesity and related health issues, credited Prescribe FIT for her 106-pound weight loss, which enabled her to engage in activities with her granddaughter that she previously could not.
The funding round saw contributions from prominent investors such as Jim Grote, Tamarind Hill, and Jobs Ohio Growth Capital. Other notable investors include orthopedic surgeons Dr. Keith Berend, Dr. David Dickerson, and Dr. Adolph Lombardi, Jr. Brock Leonti, CEO and Founder of Prescribe FIT, expressed gratitude for the continued support and new partnerships. The funds will be used to enhance technology, expand the team responsibly, and transform more patients' lives.
Prescribe FIT plans to launch several innovative solutions to extend care and improve patients' daily lives. These include remote therapeutic monitoring for pain reduction and mobility enhancement, a smoking cessation program for surgical optimization, and an AI-driven solution to boost patient engagement. The company also plans to hire additional health coaches to provide personalized care from clinical professionals.
Leonti emphasized the company's commitment to proactive, preventative, and personalized care. The goal for the next year is to expand technology to make human-centered care more scalable. Patients typically see a 5.4% body weight loss within the first 16 weeks, with 82% of those in severe pain experiencing relief and 81% of those with limited mobility seeing improvements. Some patients have been in the program for over 1,000 days, losing up to 173 pounds and significantly reducing their BMI.
Amer Ghanem, the new technology leader at Prescribe FIT, expressed excitement about the future. He highlighted the potential of AI to revolutionize healthcare in America by creating smarter healthcare experiences with improved outcomes. Jack Gainer, President and COO, pointed out that chronic diseases linked to smoking, alcohol, poor nutrition, physical inactivity, and obesity are a significant burden on the healthcare system. With over 40% of U.S. adults being obese, Prescribe FIT's efforts to address these issues are crucial.
Prescribe FIT continues to focus on musculoskeletal patients, aiming to extend its services to every private orthopedic practice in the country. In 2023, they expanded from Hawaii and Washington to New Jersey and Florida. Amanda Pinney-Kolon, VP of Physician Partnerships, noted the overwhelming success and growing demand for their services, resulting in a waitlist for providers eager to join the program. Together with their partners, Prescribe FIT has become the "Leader in Orthopedic Patient Optimization," helping patients address the root causes of their musculoskeletal issues.
